30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Bioventus Signs Contract with UnitedHealthcare Commercial Plans -

Bioventus entered into a U.S. contract with UnitedHealthcare whereby UH's commercial plan members will have access to DUROLANE and GELSYN-3 to treat knee osteoarthritis pain. DUROLANE is a single-injection and GELSYN-3, a three-injection hyaluronic acid-based joint-fluid treatment for patients. (Bioventus, 9/9/19)